에 대한 최신 뉴스 UiPath (NYSE:PATH) 주식

UiPath

UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

News

ABSI

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

화요일(21일) 캐시 우드가 이끄는 아크 인베스트는 애콜레이드(NASDAQ:ACCD), 디어(NYSE:DE), 인텔리아 테라퓨틱스(NASDAQ:NTLA), 유아이패스(NYSE:PATH), 카메코(NYSE:CCJ), 오클로(NYSE:OKLO), 일루미나(NASDAQ:ILMN), 엘빗 시스템즈(NASDAQ:ESLT), 앱사이(NASDAQ:ABSI)와 관련된 상당한 거래를 진행했다. 

아크 인베스트, 트럼프의 정책에 따라 방산주·에너지주 투자

Equities

Markets

Tech

ETFs

ARKF

CRSP

IBTA

RBLX

RDDT

금요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)가 템퍼스 AI(NASDAQ:TEM), 크리스퍼 테라퓨틱스 AG(NASDAQ:CRSP), 유아이패스(NYSE:PATH), 로블록스(NYSE:RBLX), 레딧(NYSE:RDDT),애컬레이드(NASDAQ:ACCD) 그리고 아이보타(NYSE:IBTA)와 관련된 중요한 거래를 진행했다.

아크 인베스트, 금요일 템퍼스 AI·크리스퍼 테라퓨틱스 매수 vs 유아이패스·로블록스·레딧 매도

Analyst Color

Long Ideas

Sector ETFs

Analyst Ratings

Trading Ideas

ABBNY

ISRG

NVDA

PLTR

ZBRA

미국의 경쟁력은 2025년에 네 가지 주요 투자 테마인 에너지 독립, 방산 혁신, 인프라 및 자동화가 포트폴리오 성장을 강화할 태세를 갖추면서 중심 무대로 떠오른다. 스콧 헬프스타인(Scott Helfstein)이 이끄는 글로벌 X의 2025년 투자 전망은 이러한 변혁적인 트렌드를 향후 1년 동안의 회복력의 중요한 동력으로 강조하고 있다.

2025 투자 테마: 인공지능, 에너지 및 방산이 미국 시장을 재정의

UiPath Inc

Pathfinder Bancorp Inc

PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy Inc

Pathfinder Ventures Inc

PATHFINDER VENTURES INC by PATHFINDER VENTURES INC.

Pathward Financial Inc

WIIM

APPN

BILL

CDNS

CFLT

CRWD

CVLT

DOCU

ESTC

GTLB

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

MNDY

PANW

PEGA

SNPS

Shares of software companies are trading lower after the Fed kept rates unchanged and noted that inflation remains somewhat elevated.

On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), Deere &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), Intellia Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Cameco Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>), Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>), and Absci Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>).
The trades include defense and energy companies, which have been in focus since the inauguration of Donald Trump. The President signed orders on Monday aimed at making it cheaper for companies to produce oil and gas, which could have an impact on energy companies. Defense stocks have also been in focus due to expectations of a pro-Israel stance from the new administration.
The NTLA Trade
The Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) collectively purchased 91,889 shares of Intellia Therapeutics Inc. Based on the closing price of $9.94, the total value of the trade amounts to approximately $913,580.06. This move indicates Ark&#8217;s continued confidence in the gene-editing sector.
The PATH Trade
Ark Invest sold 21,879 shares of UiPath Inc. through its ARKK fund. Given the closing price of $13.33, the trade is valued at around $291,712.07. This sale suggests a shift in Ark&#8217;s stance on the automation software company.
The DE Trade
Ark Invest&#8217;s ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>) and ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) purchased a total of 3,474 shares of Deere &amp; Co. With the closing price at $463.15, the trade is worth approximately $1,607,571.10.
The CCJ Trade
Ark Invest also bought 17,504 shares of Cameco Corp (CCJ) through its ARKQ fund, valued at approximately $937,589.44 at the closing price of $53.56.
Other Key Trades:
<ul>
<li>Oklo Inc: Ark Invest sold 50333 shares through ARKQ.</li>
<li>Elbit Systems: Ark Invest Sold 2074 shares through ARKQ and 627 shares through ARKX.</li>
<li>Illumina Inc: Ark Invest bought 15876 shares through ARKG.</li>
<li>Absci Corp: Ark Invest bought 79411 shares through ARKG.</li>
<li>Accolade Inc: Ark Invest sold 466,337 shares through ARKG.</li>
</ul>
Photo courtesy: Ark Invest

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies

On Friday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>), Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), and Ibotta Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>).
The Tempus AI Trade
Ark Invest&#8217;s Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) funds made substantial purchases of Tempus AI shares. The ARKG fund acquired 27,188 shares, while the ARKK fund bought a whopping 159,344 shares.
Based on the closing price of $35.15, the total value of these trades is approximately $6.57 million. This move aligns with Ark Invest&#8217;s <a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">recent trend of investing</a> in AI-driven companies.
The CRSP Trade
Ark Invest&#8217;s ARKG and ARKK funds also bought shares of CRISPR Therapeutics. The ARKG fund purchased 21,730 shares, while the ARKK fund added 125,690 shares.
Given the closing price of $40.53, the total value of these trades is approximately $5.96 million.
The PATH, RBLX, and RDDT Trades
On the other hand, Ark Invest sold shares of UiPath, Roblox, and Reddit. The ARKK fund offloaded 199,224 shares of UiPath, and 148,591 shares of Roblox, and the ARKW fund sold 5,215 shares of Reddit.
These sales indicate a shift in Ark Invest&#8217;s portfolio strategy.
Other Key Trades:
<ul>
<li>Ibotta Inc.: Ark Invest&#8217;s Ark Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) fund bought 4,364 shares of Ibotta.</li>
<li>Accolade Inc.: The ARKG fund sold 284,775 shares of Accolade.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In First 2 Weeks Of 2025</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Benzinga YouTube and Unsplash

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$135.00</td>
<td>$35.8K</td>
<td>84.7K</td>
<td>106.9K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$237.50</td>
<td>$42.3K</td>
<td>10.2K</td>
<td>26.6K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$425.00</td>
<td>$39.1K</td>
<td>10.1K</td>
<td>12.7K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$400.00</td>
<td>$64.6K</td>
<td>12.7K</td>
<td>11.3K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$32.00</td>
<td>$215.4K</td>
<td>286</td>
<td>2.1K</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$640.00</td>
<td>$1.2 million</td>
<td>749</td>
<td>310</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$240.00</td>
<td>$90.0K</td>
<td>2.0K</td>
<td>276</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$690.00</td>
<td>$394.9K</td>
<td>1</td>
<td>266</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$20.00</td>
<td>$26.5K</td>
<td>1.2K</td>
<td>116</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$180.00</td>
<td>$83.0K</td>
<td>2.0K</td>
<td>112</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option trade that happens to be bullish, expiring in 2 day(s) on January 17, 2025. This event was a transfer of 199 contract(s) at a $135.00 strike. The total cost received by the writing party (or parties) was $35.8K, with a price of $180.0 per contract. There were 84798 open contracts at this strike prior to today, and today 106920 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 225 contract(s) at a $237.50 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $42.3K, with a price of $188.0 per contract. There were 10238 open contracts at this strike prior to today, and today 26613 contract(s) were bought and sold. 
• Regarding MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we observe a call option sweep with bearish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 126 contract(s) at a $425.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $39.1K, with a price of $315.0 per contract. There were 10125 open contracts at this strike prior to today, and today 12793 contract(s) were bought and sold. 
• Regarding MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 380 contract(s) at a $400.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $64.6K, with a price of $170.0 per contract. There were 12705 open contracts at this strike prior to today, and today 11323 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a call option sweep that happens to be bearish, expiring in 212 day(s) on August 15, 2025. This event was a transfer of 258 contract(s) at a $32.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $215.4K, with a price of $835.0 per contract. There were 286 open contracts at this strike prior to today, and today 2177 contract(s) were bought and sold. 
• For INTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), we notice a call option trade that happens to be bearish, expiring in 156 day(s) on June 20, 2025. This event was a transfer of 300 contract(s) at a $640.00 strike. The total cost received by the writing party (or parties) was $1.2 million, with a price of $4320.0 per contract. There were 749 open contracts at this strike prior to today, and today 310 contract(s) were bought and sold. 
• For MDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>), we notice a put option trade that happens to be bearish, expiring in 16 day(s) on January 31, 2025. This event was a transfer of 150 contract(s) at a $240.00 strike. The total cost received by the writing party (or parties) was $90.0K, with a price of $600.0 per contract. There were 2089 open contracts at this strike prior to today, and today 276 contract(s) were bought and sold. 
• Regarding ASML (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>), we observe a call option sweep with neutral sentiment. It expires in 121 day(s) on May 16, 2025. Parties traded 43 contract(s) at a $690.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $394.9K, with a price of $9183.0 per contract. There were 1 open contracts at this strike prior to today, and today 266 contract(s) were bought and sold. 
• For PATH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), we notice a call option sweep that happens to be bullish, expiring in 730 day(s) on January 15, 2027. This event was a transfer of 100 contract(s) at a $20.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $265.0 per contract. There were 1280 open contracts at this strike prior to today, and today 116 contract(s) were bought and sold. 
• For SNOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), we notice a call option trade that happens to be bearish, expiring in 156 day(s) on June 20, 2025. This event was a transfer of 50 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $83.0K, with a price of $1660.0 per contract. There were 2017 open contracts at this strike prior to today, and today 112 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AAPL

ASML

INTU

MSFT

MSTR

SMCI

SNOW

10 Information Technology Stocks Whale Activity In Today's Session

Needham analyst Scott Berg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on UiPathto Hold

In the latest quarter, 9 analysts provided ratings for UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for UiPath, revealing an average target of $15.67, a high estimate of $18.00, and a low estimate of $13.00. This current average represents a 2.06% decrease from the previous average price target of $16.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736532017_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of UiPath by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeff Hickey</td>
<td>UBS</td>
<td>Announces</td>
<td>Sell</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to UiPath. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of UiPath compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of UiPath's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of UiPath's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PATH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on UiPath analyst ratings.</a>
<h2>Get to Know UiPath Better</h2>
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
<h3>UiPath's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, UiPath showcased positive performance, achieving a revenue growth rate of 8.82% as of 31 October, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: UiPath's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -3.0%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): UiPath's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.6% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.4%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into UiPath Stock: Analyst Perspectives (9 Ratings)

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and lowers the price target from $16 to $15.

Price Target

Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $15

ANET

APLD

ARBB

BLIN

CMBM

CPSH

CRNT

DELL

HIMX

IONQ

LDTC

LIDR

LOGI

MOBBW

OKTA

ORKT

PERF

SHOP

SMSI

VRME

VSAT

VUZI

XTIA

ZENV

Shares of companies within the broader tech sector are trading higher amid market strength and may be in reaction to Microsoft's plan to invest approximately $80 billion into AI data center development in FY25.

U.S. stocks were higher, with the Dow Jones index gaining over 200 points on Monday.
Shares of fuboTV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) rose sharply during Monday's session after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a <a href="https://www.benzinga.com/25/01/42816545/fubotv-and-disney-near-merger-to-create-second-largest-digital-tv-provider-shares-soar-report">virtual MVPD company.</a>
fuboTV shares jumped 140% to $3.4501 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) surged 21.7% to $23.18 after the company announced it raised $86 million in funding for December and $167 million for 2024.</li>
<li>Paycor HCM, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) gained 21.5% to $22.52. Needham analyst Scott Berg reiterated Paycor HCM with a Buy and maintained a $20 price target.</li>
<li>Vuzix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) surged 21.4% to $5.33.</li>
<li>Amprius Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) rose 19% to $3.9000.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) gained 18.3% to $18.08 after the company revealed plans for 2025 including layoffs of approximately 400 employees and other spending reduction measures.</li>
<li>Ceragon Networks Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNT#NASDAQ">CRNT</a>) rose 16.8% to $5.53.</li>
<li>LanzaTech Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) gained 16% to $1.9500.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) surged 14% to $19.96.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) rose 11% to $36.97.</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) gained 10.5% to $99.29.</li>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares rose 10.5% to $2.9100.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) gained 9% to $4.0124.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares gained 8.8% to $20.71.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) rose 8% to $291.92.</li>
<li>Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) rose 7.9% to $21.88 after BMO Capital upgraded the stock from Market Perform to Outperform and raised its price target from $25 to $31.</li>
<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) rose 7.8% to $22.24 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $19 to $27.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) gained 6.9% to $14.19.</li>
<li>Teradyne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TER#NYSE">TER</a>) surged 6.2% to $138.79 after Northland Capital Markets upgraded the stock from Market Perform to Outperform and raised its price target from $117 to $154.</li>
</ul>
Now Read This: 
<ul>
<li><a href="Cramer: 'At This Point,' SoundHound AI Rally 'Is A Short Squeeze'">Cramer: &#8216;At This Point,&#8217; SoundHound AI Rally &#8216;Is A Short Squeeze&#8217;</a></li>
</ul>

AMPX

ASAN

COIN

CPRI

FUBO

LNZA

PLUG

PYCR

QUBT

RGTI

SEDG

SERV

FuboTV, Serve Robotics, SolarEdge Technologies And Other Big Stocks Moving Higher On Monday

ADBE

ADSK

AGYS

BTCS

BTDR

BTOG

CLSK

CWAN

CYBR

DDOG

DSGX

ETWO

EVCM

EXFY

FICO

FRSH

FTNT

GREE

GRYP

HTCR

HUBS

KVYO

LMFA

LSPD

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

NCTY

NICE

NTNX

PCOR

PRCH

RAMP

RBRK

SDIG

TEAM

TRAK

TZUP

UPLD

Shares of stocks in the broader software sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

UBS analyst Jeff Hickey initiates coverage on UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sell rating and announces Price Target of $14.

Initiation

UBS Initiates Coverage On UiPath with Sell Rating, Announces Price Target of $14

U.S. competitiveness takes center stage in 2025 with four key investment themes—energy independence, defense innovation, infrastructure, and automation—poised to bolster portfolio growth. Global X's 2025 Investment Outlook, led by Scott Helfstein, highlights these transformative trends as critical drivers of resilience <a href="https://www.benzinga.com/topic/us-economy">in the coming year.</a>
<h2 class="wp-block-heading">Infrastructure Gets A Glow-Up</h2>
America&#8217;s infrastructure renaissance is going full throttle, with $700 billion in spending set to energize construction, equipment, and materials companies. This may bode well for investors in the Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>).
These stalwarts of the old economy are reinventing themselves with cutting-edge tech to expand margins—all while trading at attractive valuations compared to the broader S&amp;P 500.
<h2 class="wp-block-heading">The Defense Play: Beyond Jets &amp; Ships</h2>
Global tensions are driving a pivot from traditional defense platforms to high-tech solutions like AI-driven drones and cybersecurity systems. 
Palantir Technologies Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) Artificial Intelligence Platform and International Business Machines Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) WatsonX AI come to mind here.
Defense revenues are expected to jump nearly 10%, with margins climbing from 5.2% to 7.6%. Success will favor those adopting automation and next-generation technologies in this competitive landscape.
Read Also: <a href="https://www.benzinga.com/news/small-cap/24/12/42438879/manufacturing-tariffs-small-cap-could-steal-the-show-in-2025">Manufacturing Comeback? Strategist Expects Tariffs To Help Small-Cap Stocks But Weigh On Consumers</a>
<h2 class="wp-block-heading">Automation &amp; Onshoring: A Tech Revolution</h2>
With the U.S. accelerating its onshoring efforts, automation and AI are emerging as the driving forces powering the shift.
Software companies and data centers are prepping for a revenue surge, with mega-cap tech upping its spending on data centers to $250 billion in 2025. 
Robotics and IoT hardware could also rebound from a sales plateau, making the automation sector one to watch. Companies enabling robotics and automation such as Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), ABB (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABBNY#OTC">ABBNY</a>), Rockwell Automation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), Zebra Technologies&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>), Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) and UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) come to mind.
<h2 class="wp-block-heading">Energy Independence Goes Nuclear</h2>
Energy's next frontier? Nuclear. With mega-cap tech giants eyeing modular nuclear reactors as a green and reliable power source, demand for uranium is heating up. Beyond the U.S., countries like Japan and Germany are also jumping on the nuclear bandwagon, signaling a global shift toward energy resilience.
U.S. companies such as Constellation Energy&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), Cameco&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) and NuScale Power&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) come to mind.
Helfstein's roadmap suggests a year of targeted strategies. By aligning portfolios with these U.S.-centric themes, investors might not just weather volatility—they could thrive in the chaos.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/24/12/42437267/berkshire-palantir-etfs-add-high-octane-trading-options-with-direxions-launch">Berkshire, Palantir ETFs Add High-Octane Trading Options With Direxion&#8217;s Launch</a></li>
</ul>
Photo: Shutterstock

2025 Investment Themes: AI, Energy, Defense Redefine US Markets

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and raises the price target from $15 to $16.

Barclays Maintains Equal-Weight on UiPath, Raises Price Target to $16

Morgan Stanley analyst Keith Weiss maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and raises the price target from $15 to $16.

Morgan Stanley Maintains Equal-Weight on UiPath, Raises Price Target to $16

UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) analysts stay mostly on the sidelines with concerns for the short-term after the company reported third-quarter financial results Thursday.
The PATH Analysts: Oppenheimer analyst Brian Schwartz maintained a Perform rating on UiPath with no price target.
RBC Capital Markets analyst Matthew Hedberg maintained a Sector Perform rating with a $16 price target.
Truist analyst Terry Tillman maintained a Hold rating with a $14 price target.
KeyBanc Capital Markets analyst Jason Celino maintained a Sector Weight rating with no price target.
JPMorgan analyst Mark Murphy maintained an Overweight rating and raised the price target from $17 to $18.
Oppenheimer on PATH: Management commentary could suggest that stabilization is expected for the company next year, Schwartz said in a new investor note.
The analyst said margin growth returning and guidance for faster free cash flow growth are positives from the quarter. The negatives were soft guidance, modest billings growth and declining net new ARR (annual recurring revenue) trends, the analyst added.
"F3Q results and guidance are unlikely to alleviate investor concerns that AI is weakening the company's moat," Schwartz said.
RBC Capital on PATH: The quarterly results showed improved execution and a stable demand environment Hedberg said in a new investor note.
The analyst highlighted the company's commentary on stabilized net new ARR in the report.
"We continue to believe PATH is likely to remain range-bound over the medium term and as execution improvement plays out and the agent vision unfolds," Hedberg said.
Hedberg highlighted UiPath's commentary on early interest from customers with over 1,000 sign-ups for the Agent Builder product.
"While we like the agent vision and improved execution, we think it will take some time to see tangible benefits from agentic solutions, and we'd like to see more proof points of stability in results."
Truist on PATH: The company's growth remains sluggish going forward, Tillman said in a new investor note.
"The story remains a work in progress in terms of improving annualized renewal run-rate and returning net new ARR to a position of solid growth," Tillman said.
The analyst said the company showed progress in the third quarter with advancing partnerships and early adoption of its agentic automation.
"Sustained execution improvement remain key to growth reacceleration, in our opinion."
KeyBanc on PATH: Initial fiscal 2026 commentary was more mixed than expected, Celino said in a new investor note.
The analyst said the commentary that net new ARR dollars are expected to stabilize could be viewed as a downtick versus consensus estimates of a modest uptick.
"In terms of macro, UiPath noted trends remain largely consistent with no noticeable signs of improvements or deterioration," Celino said.
Celino said there could be long-term opportunities, but the near-term execution and growth challenges remain near-term concerns.
JPMorgan on PATH: The company showed a positive tone with its outlook and commentary, Murphy said in a new investor note.
The analyst said the company's Second Act is centered on the Agentic Model.
"UiPath appears to be making bold moves and speaking very confidently to its Agentic vision, conveying an ability to up-level conversations with customers and elevating its platform beyond just automation," Murphy said.
The new platform could open up the company for "new growth vectors," the analyst said.
"Overall, we view the performance in the quarter as solid, and see the business as mostly stable/stabilizing."
PATH Price Action: UiPath stock is down 2.47% to $14.58 on Friday versus a 52-week trading range of $10.37 to $27.87. The stock is down 39% year-to-date in 2024.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42363278/us-economy-adds-227000-jobs-in-november-wage-growth-accelerates">US Economy Adds 227,000 Jobs In November, Wage Growth Accelerates</a>
Photo: Courtesy of UiPath, Inc.

Earnings

Guidance

Movers

UiPath 'Story Remains A Work In Progress': Analysts Want To See More After Q3 Results, 'Sustained Execution Remains Key'

BMO Capital analyst Keith Bachman maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Market Perform and raises the price target from $15 to $16.

BMO Capital Maintains Market Perform on UiPath, Raises Price Target to $16

RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sector Perform and maintains $16 price target.

RBC Capital Reiterates Sector Perform on UiPath, Maintains $16 Price Target

JP Morgan analyst Mark Murphy maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Overweight and raises the price target from $17 to $18.

JP Morgan Maintains Overweight on UiPath, Raises Price Target to $18

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Friday.
Shares of Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/insights/earnings/24/12/42351795/smith-wesson-brands-q2-earnings-insights">second-quarter results</a>.
The company posted net sales of $129.7 million, an increase of 3.8%, over the year-ago period and 46.8%, over the previous quarter.
Smith &amp; Wesson Brands shares dipped 15.8% to $11.48 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) shares tumbled 81.2%</li>
<li> to $10.50 in pre-market trading after surging 599% on Thursday.</li>
<li>zSpace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) declined 31.7% to $15.01 in pre-market trading after jumping 340% on Thursday.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares tumbled 10.6% to $49.29 in pre-market trading following third-quarter results.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) fell 6.2% to $2.87 in pre-market trading.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) dipped 4.1% to $14.34 in pre-market trading following third-quarter results.</li>
<li>Douglas Dynamics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) fell 4% to $24.31 in pre-market trading.</li>
<li>Movado Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) dropped 3.3% to $20.11 in pre-market trading. The company, on Thursday, reported third-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42357598/dow-dips-more-than-200-points-ahead-of-jobs-report-investor-sentiment-declines-fear-greed-index-remains-in-greed-zone">Dow Takes A Breather After Record Close, Dips Over 200 Points Ahead Of Jobs Report: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

EGHT

ORIS

PLOW

SWBI

ZSPC

Smith & Wesson Brands, Samsara, UiPath And Other Big Stocks Moving Lower In Friday's Pre-Market Session

SA Asks: Which stocks could be helped/hurt by DeepSeek?

UiPath, with innovative product offerings, strategic initiatives, and impressive financial standings, looks poised for long-term growth. However, considering the recent market correction, is it a buy today? Read more to find out... Market corrections are a part of the stock market dynamic and can often offer attractive investment opportunities to investors. The recent scrambling of the artificial intelligence (AI) themed segment has raised portfolio concerns amongst investors about market concentration in tech megacaps. This was due to the emergence of a low-cost Chinese AI model that rattled markets and prompted concerns.
The stocks of major corporations like Nvidia, Microsoft, and Alphabet faced a big hit due to the market tumble. Further, the major indices slumped following <a href="https://www.reuters.com/markets/us/us-tech-stock-tumble-highlights-risk-market-reliance-megacaps-2025-01-28/">the news of the DeepSeek AI model</a>.
One such affected stock is UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>), a leader in robotic process automation. PATH saw its share prices drop by 5.2% in the last session. However, in the long run, the company's prospects appear promising, fueled by optimism from a potential increase in investments in Agentic AI, a probabilistic technology with high adaptability to changing environments and events.
Shares of PATH have surged 15% over the past month and 16.9% over the past six months to close the last trading session at $14.40.
PATH is a leading provider of end-to-end automation platforms that offers a range of robotic process automation (RPA) solutions internationally. It provides a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
The company reported impressive financial results in the last quarter when its subscription services revenue increased by over 23% year-over-year. PATH posted a total revenue of $354.65 million, surpassing the consensus estimate of $347.72 million. Also, its non-GAAP EPS was $0.11 for the third quarter, compared to analysts' expectations of $0.07.
PATH is an innovative automation company that leverages and integrates the latest innovations to deliver efficient and tech-first solutions. In the same attempt, it recently integrated Anthropic's Claude LLMs to fuel UiPath Autopilot for everyone, Clipboard AI, and a new GenAI healthcare solution offering improved productivity, cost savings, and decision-making capabilities to customers.
Further, UiPath's solutions are being increasingly utilized by major companies like Banco Azteca and Omega Healthcare to transform their operations and achieve significant efficiency gains with the strategic implementation of AI and automation.
Let's look at factors that could influence PATH's performance in the upcoming months.
Positive Recent Developments
On October 24, 2024, PATH announced that it is transforming the operations of Omega Healthcare, a global leader in revenue cycle management, healthcare, and clinical enablement services, through its AI-powered automation. The partnership will likely position PATH as a frontrunner in AI-driven automation.
Also, on October 22, 2024, PATH entered into a strategic partnership with Inflection AI, an enterprise AI company, to integrate the UiPath Platform with the new Inflection for Enterprise solution, which resulted in higher operational efficiency and effectiveness for enterprises.
The strategic partnership reinforces PATH's commitment to providing secure and efficient AI-driven solutions, positions it as a leader in innovative enterprise automation, and advances the security-focused industries in their operations.
Robust Financials
PATH's total revenue increased 8.8% year-over-year to $354.65 million during the third quarter that ended October 31, 2024. Its non-GAAP <a href="https://www.investopedia.com/terms/g/grossprofit.asp#:~:text=Gross%20profit%20is%20the%20income,have%20been%20removed%20from%20revenue.">gross profit</a> grew 5.8% from the year-ago value to $300.36 million. The company's non-GAAP operating income of $49.72 million indicates growth of 13.8% from the prior year's quarter.
In addition, the company's non-GAAP net income came in at $59.81 million or $0.11 per share for the quarter, respectively. Its free cash flow increased 12.2% from the year-ago value to $182.87 million.
Also, the company's cash and cash equivalents and total assets stood at $773.63 million and $2.66 billion as of October 31, 2024.
According to the fourth quarter fiscal 2025 financial outlook, PATH expects revenue between $422 million and $427 million. The company's ARR is projected to range from $1.669 billion to $1.674 billion as of January 31, 2025. Also, it expects a non-GAAP operating income of approximately $100 million
Favorable Analyst Estimates
Analysts expect PATH's revenue for the second quarter (ending July 2025) to increase 12.3% year-over-year to $355.23 million. The consensus EPS estimate of $0.07 for the same quarter reflects a 68.7% year-over-year improvement. Moreover, the company surpassed the consensus revenue and EPS estimates in all of the trailing four quarters, which is remarkable.
Additionally, for the fiscal year ending January 2026, the company's revenue and EPS are expected to grow 10.7% and 7.2% from the prior year to $1.58 billion and $0.51, respectively.
High Profitability
PATH's trailing-12-month gross profit margin of 83.38% is 65.1% higher than the industry average of 50.49%. Its trailing-12-month levered FCF margin of 31.21% is considerably higher than the industry average of 11.14%.
POWR Ratings Reflect Promise
PATH's solid fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, translating to a Buy in our proprietary system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. PATH has a B grade for Quality, in sync with its higher-than-industry-profitability.
In addition, the stock has a B grade for Momentum. PATH is currently trading above its 50-day and 200-day moving averages of $13.64 and $13.88, respectively, indicating an uptrend.
PATH is ranked #9 in the 18-stock A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry.
Beyond what I have stated above, we have also given PATH grades for Sentiment, Value, Growth, and Stability. Get access to all the PATH Ratings <a href="https://stocknews.com/stock/PATH/">here</a>.
Bottom Line
In the recent market turbulence where even the members of the ‘Magnificent Seven' group of technology stocks were affected, PATH also followed the same wave, and its stocks went through a decline. The market correction stirred the stock market and investors' reaction and could benefit investors in the long term.
This has positioned PATH as a Buy, owing to its innovative solutions, continuous AI integration, expanding customer base, and solid financial performance in the last reported quarter.
Thus, considering the stock's profitability, long-term potential, and growth prospects, it could be prudent to invest in this stock.
How Does UiPath Inc. (PATH) Stack Up Against Its Peers?
While PATH has an overall POWR Rating of B, investors could also check out these other stocks within the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry with A (Strong Buy) or B (Buy) ratings: Kaltura, Inc. (<a href="https://stocknews.com/stock/KLTR/">KLTR</a>), WM Holding Company, LLC (<a href="https://stocknews.com/stock/MAPS/">MAPS</a>), and Vimeo Inc. (<a href="https://stocknews.com/stock/VMEO/">VMEO</a>).
For exploring more A and B-rated software stocks, <a href="https://stocknews.com/category/software-saas/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
PATH shares were trading at $14.66 per share on Thursday afternoon, up $0.26 (+1.81%). Year-to-date, PATH has gained 15.34%, versus a 3.22% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/path-kltr-maps-vmeo-is-uipath-a-buy-after-its-recent-market-correction/>Is UiPath a Buy After Its Recent Market Correction?</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Is UiPath a Buy After Its Recent Market Correction?

As the robotics field progresses and enters more industries, robotics stocks are becoming increasingly promising investments. With AI-driven advancements accelerating growth, now could be an opportune time to tap into this booming sector with fundamentally sound stocks like PTC Inc. (PTC), UiPath (PATH), and FARO Technologies (FARO). Read more… Robotics continues to capture investors' attention, especially as artificial intelligence ushers in a new era of automation. From manufacturing and logistics to healthcare and everyday tasks, robotics is revolutionizing industries by enhancing efficiency, precision, and scalability.
Given the industry's strong growth potential, investors could consider solid robotics stocks PTC Inc. (<a href="https://stocknews.com/stock/PTC/">PTC</a>), UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>), and FARO Technologies, Inc. (<a href="https://stocknews.com/stock/FARO/">FARO</a>), which are at the forefront of automating industries.
The demand for robotics technology is surging across various sectors, from industrial automation and supply chain management to sales and healthcare. As AI and machine learning refine robotic capabilities, these intelligent systems learn to adapt, improving their decision-making and tackling increasingly complex tasks with remarkable precision.
Industrial robots, which handle tasks like assembly, material management, and production optimization, are expected to surge from $21.94 billion in 2025 to $55.55 billion by 2032, exhibiting a <a href="https://www.fortunebusinessinsights.com/industry-reports/industrial-robots-market-100360">CAGR of 14.2%</a>. Meanwhile, robotic-assisted surgical systems are transforming healthcare by reducing surgery times and accelerating patient recovery.
Overall, the global robotics market is projected to <a href="https://www.mordorintelligence.com/industry-reports/robotics-market#:~:text=The%20Robotics%20Market%20size%20is%20expected%20to%20reach%20USD%20100.59,to%20reach%20USD%20100.59%20billion.">hit $178.63 billion by 2030</a>, growing at a CAGR of 12.2%. AI-powered advancements further enhance robotics, enabling greater precision and adaptability in industries such as autonomous vehicles, precision agriculture, and personalized healthcare. As these technologies continue to evolve, robotics remains a promising sector for long-term investors.
Considering these conducive trends, let's examine the fundamental aspects of the featured stocks in detail:
PTC Inc. (<a href="https://stocknews.com/stock/PTC/">PTC</a>)
PTC is a global software company that enables industrial and manufacturing companies to digitally transform how they engineer, manufacture, and service physical products. Its suite of PLM solutions includes Windchill, ThingWorx, ServiceMax, Arena, Codebeamer, Servigistics, FlexPLM, and Kepware, while its CAD offerings include Creo 3D, Onshape, Vuforia, and Arbortext.
On December 3, 2024, PTC announced a partnership with Microsoft Corporation (<a href="https://stocknews.com/stock/MSFT/">MSFT</a>) and Volkswagen AG (<a href="https://stocknews.com/stock/VWAGY/">VWAGY</a>) to develop a GenAI copilot based on the PTC Codebeamer&#xAE; application lifecycle management (ALM) solution. The new Codebeamer Copilot aims to streamline software development for physical products, making creating and managing product requirements more efficient.
This collaboration is designed to enhance the value of Codebeamer by integrating Microsoft Azure's GenAI capabilities, positioning PTC to capitalize on the rapidly growing AI market.
For the fiscal 2024 fourth quarter that ended September 30, PTC's total revenue increased 14.6% year-over-year to $626.55 million. Its non-GAAP gross margin rose 18.6% from the year-ago value to $528.84 million, while its non-GAAP operating income grew 37.8% from the prior year's quarter to $276.56 million. Additionally, non-GAAP <a href="https://www.investopedia.com/terms/n/netincome.asp">net income</a> and EPS increased 29.1% and 28.3% year-over-year to $186.06 million and $1.54, respectively.
The consensus revenue estimate of $650.11 million for the fiscal second quarter (ending March 2025) represents a 7.8% increase year-over-year. The consensus EPS estimate of $1.63 for the same quarter indicates an 11.6% improvement year-over-year. The company has an excellent earnings surprise history; it surpassed the consensus EPS estimates in each of the trailing four quarters.
Over the past six months, the stock has surged 8.7%, closing the last trading session at $189.08.
PTC's stance is apparent in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has a B grade for Growth and Quality. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
Among the 127 stocks in the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry, it is ranked #50. <a href="https://stocknews.com/stock/PTC/">Click here</a> to see the additional PTC ratings (Value, Momentum, Stability, and Sentiment).
UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>)
PATH is an enterprise automation and artificial intelligence (AI) software company that provides an end-to-end automation platform that offers a variety of international robotic process automation (RPA) solutions.
On October 22, 2024, PATH announced a strategic partnership with Inflection AI to integrate the UiPath Platform&#x2122; with the new Inflection for Enterprise solution, allowing enterprises to achieve greater levels of operational efficiency and effectiveness without compromising trust and AI security options. This partnership strengthens PATH's position in enterprise automation, expanding its reach and potential adoption among major corporations.
PATH's revenues for the third quarter (ended October 31, 2024) increased 8.8% year-over-year to $354.65 million. It reported a non-GAAP gross profit of $300.36 million, indicating a 5.7% growth from the prior-year quarter.
The company's non-GAAP operating income came in at $49.72 million, up 13.8% year-over-year, while its non-GAAP net income for the quarter amounted to $59.81 million or $0.11 per share. Also, its non-GAAP adjusted free cash flow increased 12.2% year-over-year, amounting to $182.87 million.
Analysts expect PATH's revenue for the fourth quarter (ending January 2025) to increase 4.9% year-over-year to $425.45 million. The company's revenue for the fiscal year 2026 is expected to grow 10.7% year-over-year to $1.58 billion. Moreover, the company topped the consensus revenue estimates in each of the trailing four quarters.
The stock has gained 16.9% over the past six months to close the last trading session at $14.40.
PATH's POWR Ratings reflect its promising outlook. The stock has an overall rating of B, which equates to Buy in our proprietary rating system.
PATH has a B grade for Growth, Momentum, and Quality. It is ranked #9 out of 18 stocks in the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry. <a href="https://stocknews.com/stock/PATH/">Click here</a> to access the other ratings of PATH for Value, Stability and Sentiment.
FARO Technologies, Inc. (<a href="https://stocknews.com/stock/FARO/">FARO</a>)
FARO designs, develops, manufactures, markets, and supports software-driven three-dimensional measurement, imaging, and realization solutions for the manufacturing, architecture, engineering, and construction (AEC), operations and maintenance (O&amp;M), and public safety analytics markets.
On January 23, 2025, FARO expanded into the handheld scanning market with the launch of FARO Leap ST&#xAE;. This new addition enhances the company's product lineup, positioning FARO among the select few offering a full suite of portable 3D metrology devices.
The launch bolsters FARO's footprint in the manufacturing sector, where precision, efficiency, and speed are crucial. Alongside this, FARO also introduced an update to its FARO CAM2&#xAE; Software, streamlining the process of scanning parts for greater ease and effectiveness.
In October last year, the company launched the Focus Premium Max 3D Laser Scanner, which extends the scanning range to 400 meters and reduces scanning time by up to 50% with Hybrid Reality Capture. The enhanced Focus portfolio simplifies workflows for construction, geospatial, and public safety applications.
FARO's net sales for the fiscal third quarter that ended September 30, 2024, amounted to $82.56 million. The company's non-GAAP gross profit grew 9.3% year-over-year to $46.36 million. Its income from operations came in at $2.16 million compared to a loss of $6.93 million last year.
Moreover, its non-GAAP net income amounted to $3.99 million, or $0.21 per share, indicating considerable improvement from the year-ago values of $457 thousand or $0.03 per share, respectively. Also, its adjusted EBITDA stood at $8.85 million, up 151.5% year-over-year.
Street expects FARO's EPS for the quarter ended December 31, 2024, to increase 11.1% year-over-year to 0.40. Its revenue for the same period is estimated to come in at $91.40 million. It surpassed the consensus EPS estimates in each of the trailing four quarters, which is impressive.
Shares of FARO have surged 78.9% over the past six months and 20.5% year-to-date to close the last trading session at $30.55.
It's no surprise that FARO has an overall rating of A, equating to a Strong Buy in our POWR Ratings system. It also has an A grade for Growth and a B for Value, Sentiment, and Quality. It is ranked #4 out of 42 stocks in the B-rated <a href="https://stocknews.com/category/software-business/">Software – Business</a> industry.
Beyond what is stated above, we've also rated FARO for Momentum and Stability. Get all FARO ratings <a href="https://stocknews.com/stock/FARO/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
PTC shares were trading at $192.38 per share on Thursday afternoon, up $3.30 (+1.75%). Year-to-date, PTC has gained 4.63%, versus a 3.12% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Shweta Kumari</h2> <img src='https:/wp-content/uploads/2022/03/Shweta-Kumari_Image-2.jpg' style="float:left; padding:5px;width:125px;">Shweta's profound interest in financial research and quantitative analysis led her to pursue a career as an investment analyst. She uses her knowledge to help retail investors make educated investment decisions.<a href="https://stocknews.com/authors/?author=shweta-kumari">More...</a>The post <a href=https://stocknews.com/news/ptc-path-faro-msft-vwagy-3-robotics-stocks-automating-the-future-of-industry/>3 Robotics Stocks Automating the Future of Industry</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Robotics Stocks Automating the Future of Industry

The AI and data analytics market is experiencing significant growth, driven by growing demand for analytics tools and technological advancements. Thus, it could be wise to buy and hold top AI and data analytics stocks Accenture (ACN), Autodesk (ADSK), and UiPath (PATH) for significant profits. Continue reading... Organizations across various segments and industries increasingly embrace digital transformation and rely on data analytics to sort and extract necessary information for effective decision-making. Amid this, the shift towards innovative AI technology is further enhancing the efficiency and effectiveness of data analytics.
Given the current trends, it could be wise to consider buying fundamentally sound AI and data analytics stocks: Accenture plc (<a href="https://stocknews.com/stock/ACN/">ACN</a>), Autodesk, Inc. (<a href="https://stocknews.com/stock/ADSK/">ADSK</a>), and UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>), which are turning information into profit.
Recent years have evidenced the accelerated use of data analytics and AI among businesses and organizations. Also, amid the growing demand for high-efficiency data analytics tools, a focus on developing adaptive data sharing, data fabrics, and especially Artificial Intelligence (AI) systems is being promoted for growth, resilience, and innovation.
According to the International Data Corporation (IDC), worldwide AI spending will likely more than double by 2028, <a href="https://www.idc.com/getdoc.jsp?containerId=prUS52530724">reaching over $632 billion</a>. The rapid incorporation of AI and generative AI (GenAI) in a wide range of industries has fueled industry expansion and spending. The Artificial Intelligence market value is projected to grow to <a href="https://www.statista.com/outlook/tmo/artificial-intelligence/worldwide">$826.70 billion by 2030</a> at a CAGR of 27.7%.
Further, as per a report by <a href="https://www.imarcgroup.com/data-analytics-market">IMARC Group</a>, with big data and predictive analytics fueling the data analytics market growth, the market is poised to hit around $482.61 billion by 2033, expanding at a CAGR of 23.1%. Also, increasing amounts of structured and unstructured data and reliance on analytics to extract meaningful insights by organizations are shaping the data analytics market.
Besides, in the coming time, the integration of data analytics and Artificial Intelligence (AI) will expand as more and more companies seek to use AI algorithms to analyze large sums of data and extract deeper insights and patterns, resulting in better decision-making and improved efficiency.
This will create favorable tailwinds for companies engaged in analytics operations, turning information into profit. Investors could consider adding fundamentally sound AI and Data analytics stocks ACN, ADSK, and PATH to their portfolios, considering the industry's bright prospects.
Let's discuss the fundamentals of these stocks in detail:
Accenture plc (<a href="https://stocknews.com/stock/ACN/">ACN</a>)
Headquartered in Dublin, Ireland, ACN provides strategy and consulting, industry X, song, and technology and operation services internationally. It offers systems integration and application management, security, intelligent platform, infrastructure, software engineering, data and AI, and automation services.
On January 23, 2025, ACN and BCC Iccrea Group, Italy's largest cooperative banking group, signed a partnership agreement to support the Group's IT transformation within the framework of the broader IT reinvention plan devised by BCC Sistemi Informatici. The partnership will result in accelerated transformation and provide improved levels of service.
On January 16, 2025, ACN and Telstra announced their joint venture (JV) to rapidly accelerate Telstra's data and AI roadmap with the objective of extending its network leadership, improving customer experience, and helping its teams operate more efficiently and effectively.
For the first quarter that ended November 30, 2024, ACN's revenues increased 9% year-over-year to $17.69 million. Its operating income rose 14.9% from the year-ago value to $2.95 billion. Also, the company's <a href="https://www.investopedia.com/terms/n/netincome.asp">net income</a> and EPS of $2.32 billion and $3.59 indicate growth of 15.2% and 15.8% from the previous year's quarter, respectively.
As per the company's business outlook, ACN expects revenues for the second quarter of fiscal 2025 to be in the range of $16.20 billion to $16.80 billion, or 5% to 9% growth in local currency.
For the fiscal 2025, the company raised its revenue growth to be in the range of 4% to 7% in local currency, compared to the previous 3% to 6% guidance.
Analysts expect ACN's EPS for the second quarter (ending February 2025) to increase 0.8% year-over-year to $2.79, and its revenue is expected to grow 5.4% year-over-year to $16.64 billion, respectively. Moreover, the company has topped consensus EPS estimates in three of the trailing four quarters.
Shares of ACN have surged 1.1% over the past month and 10% over the past six months to close the last trading session at $363.26.
ACN's bright prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
ACN has a B grade for Quality, Momentum, Stability, and Sentiment. It is ranked #3 out of 9 stocks in the A-rated <a href="https://stocknews.com/category/outsourcing-tech-services/">Outsourcing – Tech Services</a> industry.
To check other POWR Ratings of ACN for Growth and Value, <a href="https://stocknews.com/stock/ACN/">click here</a>.
Autodesk, Inc. (<a href="https://stocknews.com/stock/ADSK/">ADSK</a>)
ADSK provides global 3D design, engineering, and entertainment technology solutions. The company offers AutoCAD Civil 3D, Autodesk Build, Revit, Autodesk BIM Collaborate Pro, and BuildingConnected.
On January 23, 2025, ADSK named Giant Spoon its first-ever creative agency of record, marking a significant step in its brand evolution. The companies will build on ADSK's recent milestones and create new campaigns to drive the business forward and deliver on ADSK's mission to help everyone, everywhere, design and make a better world.
On October 15, 2024, ADSK and Esri, the global leader in geographic information system (GIS) technology and location intelligence, expanded their strategic alliance. The integration aims to introduce Esri's authoritative geospatial reference data into Autodesk Forma to transform early design and planning stages for AECO professionals.
ADSK's total net revenue increased 11% year-over-year to $1.57 million during the third quarter that ended October 31, 2024. Its gross profit rose 10.6% year-over-year to $1.42 billion. The company's non-GAAP income from operations grew 4.8% from the year-ago value to $573 million.
Furthermore, the company's net income came in at $275 million, up 14.1% from the prior year's quarter, while its non-GAAP net income per share of $2.17 reflects growth of 4.8% year-over-year.
Street expects ADSK's revenue for the fourth quarter (ending January 2025) to increase 11% year-over-year to $1.63 billion. Its EPS for the same period is expected to grow 2.3% year-over-year to $2.14. Also, the company has surpassed consensus revenue and EPS estimates in each of the four trailing quarters.
ADSK's stock gained 22.3% over the past six months and 19.1% over the past year to close the last trading session at $301.08.
ADSK's sound fundamentals are reflected in its POWR Ratings. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
The stock has an A grade for Quality and a B for Sentiment. ADSK is ranked #26 among the 127 stocks within the <a href="https://stocknews.com/category/software-application/">Software- Application</a> industry.
<a href="https://stocknews.com/stock/ADSK/">Click here</a> to access additional ADSK ratings for Stability, Growth, Value, and Momentum.
UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>)
PATH provides an end-to-end automation platform offering a range of international robotic process automation (RPA) solutions. The company provides a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
On October 23, PATH announced the transformation of operations for Omega Healthcare, a global leader in revenue cycle management, healthcare, and clinical enablement services, through its AI-powered automation. The partnership could position PATH as a frontrunner in AI-driven automation.
On October 22, PATH entered into a strategic partnership with Inflection AI, an enterprise AI company, to integrate the UiPath Platform with the new Inflection for Enterprise solution, resulting in higher operational efficiency and effectiveness for enterprises.
The strategic partnership reinforces PATH's commitment to providing secure and efficient AI-driven solutions and will advance the security-focused industries in their operations.
On the same day, PATH announced the integration of Anthropic's large language model (LLM), Claude 3.5 Sonnet, delivering new AI features in three key products, including UiPath Autopilot for everyone, Clipboard AI, and a new medical record summarization solution.
During the third quarter that ended October 31, 2024, PATH's total revenue increased 8.8% year-over-year to $325.65 million. It reported a non-GAAP gross profit of $300.36 million, up 5.8% from the prior year's quarter. Its non-GAAP operating income increased 13.8% from the year-ago value to $49.72 million.
Additionally, the company's non-GAAP net income came in at $59.81 million or $0.11 per share for the quarter, respectively.
According to the financial outlook for the fourth quarter of 2025, UiPath expects revenue in the range of $422 million to $427 million. Its ARR is expected to be $1.669 billion to $1.674 billion, and a non-GAAP operating income of $100 million.
Analysts expect PATH's revenue and EPS for the second quarter (ending July 2025) to increase 12.3% and 68.7% year-over-year to $355.23 million and $0.07, respectively. Further, the company has surpassed the consensus revenue and EPS estimates in all of the trailing four quarters, which is impressive.
Over the past month, the stock has gained 5.1% and 12% over the past six months to close the last trading session at $13.79.
PATH's POWR Ratings reflect its robust outlook. The stock has an overall B rating, translating to a Buy in our proprietary rating system.
PATH has a B grade for Growth, Value, and Quality. It is ranked #9 among 18 stocks within the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry.
To see the other ratings of PATH for Sentiment, Stability, and Momentum, <a href="https://stocknews.com/stock/PATH/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
ACN shares were trading at $362.62 per share on Friday afternoon, down $0.64 (-0.18%). Year-to-date, ACN has gained 3.52%, versus a 3.66% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/acn-adsk-path-3-ai-data-analytics-stocks-turning-information-into-profit/>3 AI & Data Analytics Stocks Turning Information into Profit</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 AI & Data Analytics Stocks Turning Information into Profit

Comments

UiPath

뉴스

에 대한 최신 뉴스 UiPath (NYSE:PATH) 주식

수요일, 1월 22, 2025

일요일, 1월 19, 2025

목요일, 12월 12, 2024

목요일, 12월 05, 2024

금요일, 11월 01, 2024

금요일, 9월 06, 2024

목요일, 9월 05, 2024

화요일, 7월 16, 2024

수요일, 5월 29, 2024

화요일, 4월 16, 2024

금요일, 4월 12, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌